BioSpace News Archive

Drug Development

Sarepta Therapeutics Reports Long-Term Outcomes Through 168 Weeks From Phase 2b Study Of Eteplirsen In Duchenne Muscular Dystrophy

January 12, 2015
·
18 min read
Drug Development

Arrowhead Research Corporation Provides Update On IND For ARC-520 Phase 2b Study

January 12, 2015
·
4 min read
BioMidwest

Fresenius Kabi AG Receives FDA Status Upgrade For New York Manufacturing Center

January 12, 2015
·
1 min read
Drug Development

Alnylam Pharmaceuticals Reports Initial Evidence For Potential Correction Of The Hemophilia Phenotype In Phase 1 Study Of ALN-AT3, A Subcutaneously Administered, Investigational RNAi Therapeutic Targeting Antithrombin For The Treatment Of Hemophilia

January 12, 2015
·
17 min read
Deals

AmerisourceBergen Corporation To Acquire MWI Veterinary Supply, The Leading Animal Health Distribution Company In The United States

January 12, 2015
·
1 min read
Biotech Bay

Vertex Pharmaceuticals Incorporated Outlines 2015 Business Priorities To Support The Development, Approval And Launch Of New Medicines For The Treatment Of People With Cystic Fibrosis

January 12, 2015
·
1 min read
NRGene’s Big Data Technology To Enable The International Maize And Wheat Improvement Centre’s (CIMMYT) Maize Genome Analysis

January 12, 2015
·
3 min read
Genetown

CluePoints SaaS Solution Demonstrates Improved Data Integrity & Quality By Putting Sponsors In Control Of Risk-Based Monitoring

January 12, 2015
·
3 min read
CARMAT - Financial Agenda 2015

January 12, 2015
·
1 min read
Biotech Beach

Cure Duchenne Ventures LLC To Provide $1 Million To Capricor Therapeutics, Inc. To Advance Promising Research To Treat Heart Disease Associated With Duchenne Muscular Dystrophy

January 12, 2015
·
4 min read